Lane Labs ordered to refund money
The FDA has ordered a refund program be established, following a federal district court ruling that Lane Labs USA marketed three products as treatments for cancer, HIV, and skin cancer without FDA approval. Consumers who purchased BeneFin, MGN-3, and SkinAnswer between Sept. 22, 1999, and July 12, 2004, are eligible for a partial refund of the purchase price and any shipping and handling costs.
Lane Labs ordered to refund money
The FDA has ordered a refund program be established, following a federal district court ruling that Lane Labs USA marketed three products as treatments for cancer, HIV, and skin cancer without FDA approval. Consumers who purchased BeneFin, MGN-3, and SkinAnswer between Sept. 22, 1999, and July 12, 2004, are eligible for a partial refund of the purchase price and any shipping and handling costs. A copy of the claim form can be obtained at http://www.gilardi.com/lanelabs/.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
Podcast: Discussing the Shared Central Fulfillment Solution with iA
May 6th 2024Brian Nowosielski, associate editor with Drug Topics, sat down with Tom Utech and Reed Richardson of iA, an innovative pharmacy fulfillment company. Utech, CEO of iA, and Richardson, Chief Commercial Officer of iA, discussed the company's new shared central fulfillment solution. The new solution, designed to streamline processes within the pharmacy, is a technological innovation with life-saving benefits for patients.
